Tricuspid atresia natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
| (6 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | |||
Early clinical features in infants include [[ cyanosis]] of [[lips]] and [[tongue]], [[difficulty in breathing]], [[tiring easily during feeding]]. The severity of [[cyanosis]] in [[ infants]] with [[ pulmonary stenosis]] is dependent on the amount of [[ pulmonary blood flow ]]passing through [[ patent ductus arteriosus]]. After physiologic closure of [[ patent ductus arteriosus]] (PDA), the [[ cyanosis]] will be aggravated. In patients with normal [[ pulmonary blood flow]], complications of [[ heart failure]] may occur. Prognosis is generally poor without [[surgery ]] and 90% of patients will die before 10 years old. | |||
== Natural History, Complications and Prognosis == | == Natural History, Complications and Prognosis == | ||
* Early clinical features in infants include [[ cyanosis]] of [[lips]] and [[tongue]], [[difficulty in breathing]], [[tiring easily during feeding]]. | * Early clinical features in infants include [[ cyanosis]] of [[lips]] and [[tongue]], [[difficulty in breathing]], [[tiring easily during feeding]]. | ||
* The severity of [[cyanosis]] in[[ infants]] with [[ pulmonary stenosis]] is dependent on the amount of[[ pulmonary blood flow ]]passing through[[ patent ductus arteriosus]]. | * The severity of [[cyanosis]] in [[ infants]] with [[ pulmonary stenosis]] is dependent on the amount of [[ pulmonary blood flow ]]passing through [[ patent ductus arteriosus]]. | ||
* After physiologic closure of [[ patent ductus arteriosus]] (PDA), the[[ cyanosis]] will be aggravated. | * After physiologic closure of [[ patent ductus arteriosus]] (PDA), the [[ cyanosis]] will be aggravated. | ||
* In patients with normal [[ pulmonary blood flow]], complications of[[ heart failure]] may occur. | * In patients with normal [[ pulmonary blood flow]], complications of [[ heart failure]] may occur. | ||
* Prognosis is generally poor without [[surgery ]] and 90% of patients will die before 10 years old. | * Prognosis is generally poor without [[surgery ]] and 90% of patients will die before 10 years old. | ||
* The 15-year survival of patients with [[Fontan procedure]] is approximately %92 | * The 15-year survival of patients with [[Fontan procedure]] is approximately %92.<ref name="MeryDe León2019">{{cite journal|last1=Mery|first1=Carlos M.|last2=De León|first2=Luis E.|last3=Trujillo-Diaz|first3=Daniel|last4=Ocampo|first4=Elena C.|last5=Dickerson|first5=Heather A.|last6=Zhu|first6=Huirong|last7=Adachi|first7=Iki|last8=Heinle|first8=Jeffrey S.|last9=Fraser|first9=Charles D.|last10=Ermis|first10=Peter R.|title=Contemporary Outcomes of the Fontan Operation: A Large Single-Institution Cohort|journal=The Annals of Thoracic Surgery|volume=108|issue=5|year=2019|pages=1439–1446|issn=00034975|doi=10.1016/j.athoracsur.2019.05.039}}</ref> | ||
* Complications of [[Fontan procedure]] include:<ref name="FredenburgJohnson2011">{{cite journal|last1=Fredenburg|first1=Tyler B.|last2=Johnson|first2=Tiffanie R.|last3=Cohen|first3=Mervyn D.|title=The Fontan Procedure: Anatomy, Complications, and Manifestations of Failure|journal=RadioGraphics|volume=31|issue=2|year=2011|pages=453–463|issn=0271-5333|doi=10.1148/rg.312105027}}</ref> | |||
**[[Exercise intolerance]] due to [[ventricular failure]] | |||
*[[Exercise intolerance]] due to [[ventricular failure]] | **[[Pericardial effusion]] and[[ pleural effusion]], [[chylothorax]] and [[protein-losing enteropathy]] due to [[lymphatic dysfunction]] | ||
*[[Pericardial effusion]] and[[ pleural effusion]], [[chylothorax]] and [[protein-losing enteropathy]] due to [[lymphatic dysfunction]] | **[[Pulmonary embolism]], blood clot formation in shunt | ||
*[[Pulmonary embolism]], blood clot formation in shunt | **[[Liver failure]] and portal hypertension as a result of increased pressure in the shunt | ||
*[[Liver failure]] and portal hypertension as a result of increased pressure in the shunt | **[[leakage]] of the[[ anastomosis]] | ||
*[[leakage]] of the[[ anastomosis]] | **[[Pulmonary hypertension]] | ||
*[[Pulmonary hypertension]] | **[[Right atrium]] dilation | ||
*[[Right atrium]] dilation | **[[Arrhythmia]] | ||
*[[Arrhythmia]] | |||
==References== | ==References== | ||
Latest revision as of 16:15, 8 November 2020
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia natural history, complications and prognosis |
|
FDA on Tricuspid atresia natural history, complications and prognosis |
|
CDC on Tricuspid atresia natural history, complications and prognosis |
|
Tricuspid atresia natural history, complications and prognosis in the news |
|
Blogs on Tricuspid atresia natural history, complications and prognosis |
|
Risk calculators and risk factors for Tricuspid atresia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief:Sara Zand, M.D.[2] Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4] Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]
Overview
Early clinical features in infants include cyanosis of lips and tongue, difficulty in breathing, tiring easily during feeding. The severity of cyanosis in infants with pulmonary stenosis is dependent on the amount of pulmonary blood flow passing through patent ductus arteriosus. After physiologic closure of patent ductus arteriosus (PDA), the cyanosis will be aggravated. In patients with normal pulmonary blood flow, complications of heart failure may occur. Prognosis is generally poor without surgery and 90% of patients will die before 10 years old.
Natural History, Complications and Prognosis
- Early clinical features in infants include cyanosis of lips and tongue, difficulty in breathing, tiring easily during feeding.
- The severity of cyanosis in infants with pulmonary stenosis is dependent on the amount of pulmonary blood flow passing through patent ductus arteriosus.
- After physiologic closure of patent ductus arteriosus (PDA), the cyanosis will be aggravated.
- In patients with normal pulmonary blood flow, complications of heart failure may occur.
- Prognosis is generally poor without surgery and 90% of patients will die before 10 years old.
- The 15-year survival of patients with Fontan procedure is approximately %92.[1]
- Complications of Fontan procedure include:[2]
- Exercise intolerance due to ventricular failure
- Pericardial effusion andpleural effusion, chylothorax and protein-losing enteropathy due to lymphatic dysfunction
- Pulmonary embolism, blood clot formation in shunt
- Liver failure and portal hypertension as a result of increased pressure in the shunt
- leakage of theanastomosis
- Pulmonary hypertension
- Right atrium dilation
- Arrhythmia
References
- ↑ Mery, Carlos M.; De León, Luis E.; Trujillo-Diaz, Daniel; Ocampo, Elena C.; Dickerson, Heather A.; Zhu, Huirong; Adachi, Iki; Heinle, Jeffrey S.; Fraser, Charles D.; Ermis, Peter R. (2019). "Contemporary Outcomes of the Fontan Operation: A Large Single-Institution Cohort". The Annals of Thoracic Surgery. 108 (5): 1439–1446. doi:10.1016/j.athoracsur.2019.05.039. ISSN 0003-4975.
- ↑ Fredenburg, Tyler B.; Johnson, Tiffanie R.; Cohen, Mervyn D. (2011). "The Fontan Procedure: Anatomy, Complications, and Manifestations of Failure". RadioGraphics. 31 (2): 453–463. doi:10.1148/rg.312105027. ISSN 0271-5333.